← All trials
NCT05030831
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 22, 2021
- Primary completion
- Apr 30, 2023
- Completion date
- May 31, 2023
- First posted
- Sep 1, 2021
- Last posted
- Sep 27, 2021
- Enrollment
- 9
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Inozyme PharmaLead sponsor
- IQVIACollaborator
- Inozyme PharmaStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.